Literature DB >> 26921372

The Broadly Neutralizing, Anti-HIV Antibody 4E10: an Open and Shut Case?

Roland K Strong1, Kathryn A K Finton2.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 26921372      PMCID： PMC4810635          DOI： 10.1128/JVI.02935-15

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  11 in total

1.  Role of HIV membrane in neutralization by two broadly neutralizing antibodies.

Authors:  S Munir Alam; Marco Morelli; S Moses Dennison; Hua-Xin Liao; Ruijun Zhang; Shi-Mao Xia; Sophia Rits-Volloch; Li Sun; Stephen C Harrison; Barton F Haynes; Bing Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-11       Impact factor: 11.205

2.  Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41.

Authors:  Rosa M F Cardoso; Michael B Zwick; Robyn L Stanfield; Renate Kunert; James M Binley; Hermann Katinger; Dennis R Burton; Ian A Wilson
Journal:  Immunity       Date:  2005-02       Impact factor: 31.745

3.  Computational design of epitope-scaffolds allows induction of antibodies specific for a poorly immunogenic HIV vaccine epitope.

Authors:  Bruno E Correia; Yih-En Andrew Ban; Margaret A Holmes; Hengyu Xu; Katharine Ellingson; Zane Kraft; Chris Carrico; Erica Boni; D Noah Sather; Camille Zenobia; Katherine Y Burke; Tyler Bradley-Hewitt; Jessica F Bruhn-Johannsen; Oleksandr Kalyuzhniy; David Baker; Roland K Strong; Leonidas Stamatatos; William R Schief
Journal:  Structure       Date:  2010-09-08       Impact factor: 5.006

4.  Structural basis of enhanced binding of extended and helically constrained peptide epitopes of the broadly neutralizing HIV-1 antibody 4E10.

Authors:  Rosa M F Cardoso; Florence M Brunel; Sharon Ferguson; Michael Zwick; Dennis R Burton; Philip E Dawson; Ian A Wilson
Journal:  J Mol Biol       Date:  2006-11-10       Impact factor: 5.469

5.  Interactions between lipids and human anti-HIV antibody 4E10 can be reduced without ablating neutralizing activity.

Authors:  Hengyu Xu; Likai Song; Mikyung Kim; Margaret A Holmes; Zane Kraft; George Sellhorn; Ellis L Reinherz; Leonidas Stamatatos; Roland K Strong
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

6.  Aromatic residues at the edge of the antibody combining site facilitate viral glycoprotein recognition through membrane interactions.

Authors:  Erin M Scherer; Daniel P Leaman; Michael B Zwick; Andrew J McMichael; Dennis R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

7.  Stapled HIV-1 peptides recapitulate antigenic structures and engage broadly neutralizing antibodies.

Authors:  Gregory H Bird; Adriana Irimia; Gilad Ofek; Peter D Kwong; Ian A Wilson; Loren D Walensky
Journal:  Nat Struct Mol Biol       Date:  2014-11-24       Impact factor: 15.369

8.  Ontogeny of recognition specificity and functionality for the broadly neutralizing anti-HIV antibody 4E10.

Authors:  Kathryn A K Finton; Della Friend; James Jaffe; Mesfin Gewe; Margaret A Holmes; H Benjamin Larman; Andrew Stuart; Kevin Larimore; Philip D Greenberg; Stephen J Elledge; Leonidas Stamatatos; Roland K Strong
Journal:  PLoS Pathog       Date:  2014-09-25       Impact factor: 6.823

9.  Structural and Thermodynamic Basis of Epitope Binding by Neutralizing and Nonneutralizing Forms of the Anti-HIV-1 Antibody 4E10.

Authors:  Edurne Rujas; Naveed Gulzar; Koldo Morante; Kouhei Tsumoto; Jamie K Scott; José L Nieva; Jose M M Caaveiro
Journal:  J Virol       Date:  2015-09-16       Impact factor: 5.103

10.  Autoreactivity and exceptional CDR plasticity (but not unusual polyspecificity) hinder elicitation of the anti-HIV antibody 4E10.

Authors:  Kathryn A K Finton; Kevin Larimore; H Benjamin Larman; Della Friend; Colin Correnti; Peter B Rupert; Stephen J Elledge; Philip D Greenberg; Roland K Strong
Journal:  PLoS Pathog       Date:  2013-09-26       Impact factor: 6.823
View more
  1 in total

1.  Reply to "The Broadly Neutralizing, Anti-HIV Antibody 4E10: an Open and Shut Case?".

Authors:  Edurne Rujas; Naveed Gulzar; Koldo Morante; Kouhei Tsumoto; Jamie K Scott; José L Nieva; Jose M M Caaveiro
Journal:  J Virol       Date:  2016-02-26       Impact factor: 5.103
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.